Harbert Discovery Fund, LP 4
4 · ENZO BIOCHEM INC · Filed Mar 17, 2021
Insider Transaction Report
Form 4
HARBERT MANAGEMENT CORP
10% Owner
Transactions
- Sale
Common Stock
2021-03-16$4.54/sh−100,000$453,900→ 5,175,913 total(indirect: See footnote) - Sale
Common Stock, $0.01 par value ("Common Stock")
2021-03-15$4.75/sh−100,000$475,000→ 5,520,681 total(indirect: See footnote) - Sale
Common Stock
2021-03-15$5.00/sh−44,768$223,840→ 5,475,913 total(indirect: See footnote) - Sale
Common Stock
2021-03-16$4.70/sh−200,000$940,000→ 5,275,913 total(indirect: See footnote)
Footnotes (1)
- [F1]The securities reported herein are held by Harbert Discovery Fund, LP (the "Discovery Fund") and Harbert Discovery Co-Investment Fund I, LP (the "Discovery Co-Investment Fund" and together with the Discovery Fund, the "Funds"). Harbert Discovery Fund GP, LLC ( the "Discovery Fund GP") is the general partner of the Discovery Fund, and Harbert Discovery Co-Investment Fund I GP, LLC is the general partner of the Discovery Co-Investment Fund (and together with Harbert Discovery Fund GP, the "Fund GPs"). Harbert Fund Advisors, Inc. is the investment adviser to the Funds. Harbert Management Corporation ("HMC") is the managing member of the Fund GPs. Jack Bryant is a Senior Advisor to the Discovery Fund, and a Vice President and Senior Managing Director of HMC. Kenan Lucas is the managing director and portfolio manager of the Funds. Raymond Harbert is the controlling shareholder, Chairman and Chief Executive Officer of HMC.